Search
Patexia Research
Case number 2:23-cv-00125

ASTELLAS PHARMA INC. et al v. QILU PHARMA, INC. et al > Documents

Date Field Doc. No.Description (Pages)
Apr 28, 2023 4 NOTICE of Voluntary Dismissal by All Plaintiffs (BROWN, DANIEL) (Entered: 04/28/2023) (2)
Jan 12, 2023 3 Summons Issued as to QILU PHARMA, INC., QILU PHARMACEUTICAL CO., LTD.. Forwarded To: Daniel J. Brown on 1/12/23 (fdc) (Entered: 01/12/2023) (2)
Jan 11, 2023 1 COMPLAINT against All Defendants ( Filing fee $ 402 receipt number APAEDC-16424878.), filed by ASTELLAS PHARMA INC., ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC., ASTELLAS IRELAND CO., LTD.. (Attachments: # 1 Civil Cover Sheet, # 2 Designation Form, # 3 Supplement, # 4 Supplement, # 5 Exhibit Exhibit A)(BROWN, DANIEL) (Entered: 01/11/2023) (0)
Jan 11, 2023 2 Disclosure Statement Form pursuant to FRCP 7.1 by ASTELLAS IRELAND CO., LTD., ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC., ASTELLAS PHARMA INC..(BROWN, DANIEL) (Entered: 01/11/2023) (3)
Menu